Barbi Manchester has lived with Lupus for 13 years and has taken hydroxychloroquine to treat it for just as long. 'I've never had any issues,' said Manchester, a Lupus Foundation of America advocate and ambassador. After reaching out to multiple pharmacies, Manchester eventually found
Barbi Manchester has lived with Lupus for 13 years and has taken hydroxychloroquine to treat it for just as long.
The Federal Drug Administration on Tuesday said the country is now facing a shortage of the drugs hydroxychloroquine and chloroquine, noting"a significant surge in demand." This comes after the drugs received substantial attention around the possibility that they could be beneficial in treating COVID-19 patients.
The Department of Health and Human Services said it accepted 30 million doses of hydroxychloroquine sulfate and one million doses of chloroquine phosphate"for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.""Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients.
The Lupus Foundation of America, American College of Rheumatology, American Academy of Dermatology, and the Arthritis Foundation last month sent a joint letter to the White House Coronavirus Task Force voicing concerns that"increased demand for these drugs attributed to COVID-19 has exacerbated their already limited availability for patients who rely on them to meet their medical needs."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Doctors fear shortage of drug critical to ventilator treatment for coronavirusAs states sound the alarm over a lack of ventilators to help hospitalized novel coronavirus patients -- including a plea for 30,000 machines for New York state alone -- experts warned that even if the equipment arrives, facilities could face a shortage of health care workers trained to use them. '
Consulte Mais informação »
How Coronavirus Home Testing Works, And Why They're Hard To ApproveThe FDA has still not authorized companies to sell at-home tests to the general public, even though there are still coronavirus test shortages across the US See how this COVID-19 test can be done from your living room:
Consulte Mais informação »
Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the PandemicToday, US_FDA issued guidance for immediate implementation to address the urgent & immediate need for blood & blood components. More:
Consulte Mais informação »
Doctors fear shortage of drug critical to ventilator treatment for coronavirusSome hospitals and health care workers are worried that they will run short on personnel and drugs needed to use ventilators on critically-ill COVID19 patients.
Consulte Mais informação »
Japanese Prime Minister's coronavirus mask plan criticized as insufficient as emergency loomsJapanese Prime Minister Shinzo Abe is facing a public backlash after he said the government would distribute two reusable cloth face masks per household amid growing concern over medical shortages as the country faces a worsening coronavirus outbreak.
Consulte Mais informação »